IL6 and cancer: Our studies also indicated that DMXAA activated TNF-α/IL-6 pathways in both cancer and stromal cells and caused transcription factors downstream of these pathways, such as NF-κB, to promote the expression of their transcriptional targets, including molecules that are themselves involved in TNF-α/IL-6 signalling.